Genethera, Inc. operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Genethera with three other
pharmaceutical manufacturers in North America:
CEL-SCI Corporation
(2008
sales of $5,065.00
of which 100%
was Pharmaceutical Prod),
OXiGENE, Inc.
($12,000.00
of which 100%
was Physical Research), and
Carrus Capital Corp
which is
based in Canada
(6,000.00 Canadian Dollars [US$5,905.50 ]
).
Sales Analysis.
Sales fell dramatically in 2008:
Genethera reported sales of $10,822.00
for the
year ending
December of 2008.
This
represents
a
sharp
decrease of 88.9%
versus 2007, when the company's sales were $97,900.00 .
Business Description